BRIEF published on 05/13/2026 at 07:05, 1 month 21 days ago SCHOTT Pharma annonce un premier semestre résilient et un flux de trésorerie solide SCHOTT Pharma Croissance Des Revenus Marge D'EBITDA Des Flux De Trésorerie Résultats De La Première Mi-temps
BRIEF published on 05/13/2026 at 07:05, 1 month 21 days ago SCHOTT Pharma Reports Resilient First Half and Strong Cash Flow Revenue Growth Cash Flow EBITDA Margin SCHOTT Pharma First Half Results
PRESS RELEASE published on 05/13/2026 at 07:00, 1 month 21 days ago SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow SCHOTT Pharma reports robust first half with strong cash flow, exceeding revenue forecast and confirming full-year outlook for 2026 Financial Results Revenue Cash Flow SCHOTT Pharma H1 2026
BRIEF published on 02/11/2026 at 07:05, 4 months 20 days ago SCHOTT Pharma annonce un bon début d'année 2026 SCHOTT Pharma Augmentation Des Revenus Croissance De L'EBITDA Exercice Financier 2026 Solutions De Confinement Des Médicaments
BRIEF published on 02/11/2026 at 07:05, 4 months 20 days ago SCHOTT Pharma Reports a Strong Beginning to 2026 Revenue Increase SCHOTT Pharma EBITDA Growth Financial Year 2026 Drug Containment Solutions
PRESS RELEASE published on 02/11/2026 at 07:00, 4 months 20 days ago SCHOTT Pharma with positive start to financial year 2026; outlook confirmed SCHOTT Pharma reports positive Q1 results for 2026 with revenue growth and increased EBITDA margin. Outlook confirmed for the year Revenue Growth EBITDA Margin SCHOTT Pharma Q1 Results 2026 Outlook
BRIEF published on 02/03/2026 at 15:05, 5 months ago All Resolutions Passed at SCHOTT Pharma's AGM Shareholders Dividend Pharmaceutical AGM Resolutions
BRIEF published on 02/03/2026 at 15:05, 5 months ago Toutes les résolutions ont été adoptées lors de l'assemblée générale annuelle de SCHOTT Pharma. Actionnaires Dividende Resolutions Assemblée Générale Annuelle Pharmaceutique
PRESS RELEASE published on 02/03/2026 at 15:00, 5 months ago Successful Annual General Meeting for SCHOTT Pharma: All resolutions approved SCHOTT Pharma AG & Co. KGaA had a successful Annual General Meeting with all resolutions approved, including a dividend of 0.18 EUR per share for fiscal year 2025 Annual General Meeting Shareholders Dividend SCHOTT Pharma Resolutions
BRIEF published on 12/11/2025 at 07:05, 6 months 23 days ago SCHOTT Pharma Achieves Full-Year Revenue and Profitability Targets Revenue Growth EBITDA Margin SCHOTT Pharma Drug Delivery Systems Drug Containment Solutions
Published on 07/03/2026 at 23:00, 1 hour 14 minutes ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 2 hours 46 minutes ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 4 hours 44 minutes ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 10 hours 44 minutes ago Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation
Published on 07/03/2026 at 19:00, 5 hours 13 minutes ago PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 5 hours 18 minutes ago Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 18:14, 5 hours 59 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/03/2026 at 18:00, 6 hours 13 minutes ago Charwood Energy: W&nergy, a subsidiary of Charwood Energy, is launching a €2 million crowdfunding campaign on Enerfip.
Published on 07/03/2026 at 18:00, 6 hours 13 minutes ago Charwood Energy: W&nergy, filiale de Charwood Energy, lance une levée de fonds participative de 2 M€ sur Enerfip.
Published on 07/03/2026 at 21:49, 2 hours 24 minutes ago Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 2 hours 24 minutes ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 5 hours 31 minutes ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 5 hours 37 minutes ago Disclosure of transactions in own shares from July 1 to July 3, 2026
